Investigation of Spectrophotometric For Determination of Cloxacillin Sodium in Different Brands of Pharmaceutical Preparations
Investigation of Spectrophotometric For Determination of Cloxacillin Sodium in Different Brands of Pharmaceutical Preparations
Research Article
C
loxacillin is semi-synthetic antibiotic related to Molecular weight: 475.94,5
penicillin,1 and is also isoxazolyl penicillin.2
Characters
Cloxacillin is used in treatment of infections due to
staphylococci resistance to benzyl penicillin. It is A white, hygroscopic, crystalline powder, soluble in
administered by orally or by injection as sodium salt.2 methanol, alcohol and freely soluble in water. In the
present study an attempt was made to develop an
Cloxacillin is a bactericidal with mode of action similar to
innovative, less expensive, a simple and more authentic
benzyl penicillin. It’s active against pancillinase- producing
method for the determination of Cloxacilin Sodium in
and non-pencillinase-producing staphylococci. It’s activity
pure state and its pharmaceutical preparations.5
against streptococci such as Streptococcus pneumonia
and str. Pyogenes is less than that of benzylpenicilline, Spectrophotometric determination method
but sufficient to be useful when these organisms are development strategy for Cloxacilin sodium
present with penicillin resistant staphylococci. Cloxacillin
The presence of carboxylic acid functional group in the
is virtually ineffective against Enterococcus faecalis
2 formula of drug suggests the possibility of complexation
Resistance.
with transition metal offering a possibility for its
Cloxacillin is incompletely absorbed from the spectrophotometric determination. Therefore in the
gastrointestinal tract, after an oral dose of 500mg, peak proposed method Cloxacilin sodium was tried for its
plasma concentration of 7-15 µg/mL in fasting subjects in complex formation with various transition metals such as
1-2 hours. Absorption is more complete when given Cr, Ni, V, Cu to give a colored product. The colored
intramuscular injection and peak plasma concentration of product thus formed was used for the determination of
about 15 µg/mL is observed in 30 minutes after a dose of Cloxacilin sodium.
500mg. drug has been reported to have plasma half life of
MATERIALS AND METHODS
0.5-1 Hour.2
Preliminary Study of the chelation potential for
The chemical structure of Cloxacilin Sodium is shown in
3-5 spectrophotometric determination of Cloxacilin sodium
Figure 1.
Preliminary determinations were conducted to explore
the possibility of the formation of expected colored
complex between metal ion and Cloxacilin sodium.
Initially higher concentration of Cloxacilin sodium
(1000ppm) was treated with different metal ion solution
Figure 1: The structural formula of cloxacillin sodium along with heating to check the formation of expected
colored product. The colored product indicates the Investigation of the effect of metal ion solution and
chances of reaction and subsequent formation of incubation time on the formation and absorbance
Cloxacilin sodium complex by this method. Further behavior of complex.
studies were focused on the optimization of various
Instrument: The same as mention before
parameters for maximum complexation and are discussed
below. Reagent: The same as mention before
Investigation of appropriate wavelength for the Solution: The same as mention before
estimation of Cloxacilin metal complex
Procedure
Instruments
Standard Cloxacilin sodium solutions 2 mL from (1000
Digital analytical balance, thermostatic water bath and ppm) stock solutions were transferred to six separate 50
UV/VIS spectrophotometer were used during this mL volumetric flasks and to each of these flasks, varied
investigation. volumes of metal ion solution from (1000 ppm) stock
solution was added along with little dilution with distilled
Reagents
water and was incubated in water bath for 20 minute.
Analytical reagent grade copper nitrate trihydrate and The resulting colored complex was allowed to cool and
Cloxacilin sodium were used during this work. diluted to 50 mL with distilled water. Blank was prepared
in the same manner without the addition of Cloxacilin
Solution Preparation
sodium. The absorbance of the resulting complex was
Metal Ion Solution measured at 450 nm using Genesys 5 spectrophotometer.
The results are given in Table 2 and are shown in Figure 3.
Metal Ion solution (1000ppm) was prepared by dissolving
For studying the effect of incubation time Standard
0.380g of Cu(NO3)2.3H2O in distilled water and diluted to
Cloxacilin sodium solution 2 mL from 1000 ppm stock
100 mL with distilled water.
solution was transferred to six separate 50 mL volumetric
Standard Cloxacilin Sodium solution flasks. To each of these flask 20 mL of metal ion solution
form stock solution and little volume of water was added
Cloxacilin sodium (1000ppm) stock solution was prepared
followed by incubation in boiling water bath for varied
by dissolving 0.1 g of authentic standard Cloxacilin
times, in a range of 0-25 minutes. The resulting yellow
sodium in distilled water and diluted upto 100 mL with
colored complex was cooled and diluted to 50 mL with
distilled water.
distilled water. Blank was prepared in the same manner
Procedure without the addition of Cloxacilin sodium. The
absorbance of the resulting complex was measured at
Cloxacilin sodium 2 mL from (1000 pm) stock solution was
450 nm using Genesys 5 spectrophotometer. The results
slowly transferred to 50 mL volumetric flask. To this 10
are given in Table 3 and are shown in Figure-4.
mL of metal ion solution from (1000 ppm) stock solution
of metal ion was added with little dilution with water
followed by incubation in boiling water bath for 20
minute. The contents were allowed to cool to room
temperature in tape water tub, and diluted to 50 mL with
distilled water. Blank solution was prepared by the same
procedure without addition of Cloxacilin sodium. The
absorbance of yellow colored complex was measured
from 400-570 nm, using Genesys 5 spectrophotometer.
Each time after changing wavelength the instrument
calibrated with blank solution.
Figure 3: Optimization of the incubation time for the
The results are given in Table 1 and are shown in Figure 2. formation of complex
Figure 2: Wavelength optimization for Figure 4: Optimization of volume of metal ion solution for
spectrophotometric determination of cloxacillin sodium formation of complex
Table 7: Application of investigated method for the analysis of cloxacillin sodium in various pharmaceutical preparations
and comparison with official method
Auropen capsules 250 mg/capsule 251.31±1.13 mg/ capsule 251.83±1.41 mg/ capsule
Auropen inj 250 mg/vial 2.49.8±0.59 mg/vial 250.4±0.87 mg/vial
Cloxazan Capsules 250 mg/capsule 253.2±1.64 mg/ capsule 252.9±0.92 mg/ capsule